BDBM450562 N-Cyclopropyl-N-[(3,4-dichlorophenyl)methyl]-2-[6-[1-(2-methoxyacetyl)piperidin-4-yl]-4-oxoquinazolin-3-yl]acetamide::US10676446, Example 146

SMILES COCC(=O)N1CCC(CC1)c1ccc2ncn(CC(=O)N(Cc3ccc(Cl)c(Cl)c3)C3CC3)c(=O)c2c1

InChI Key InChIKey=OERODERTWKPXHB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 450562   

TargetAutotaxin(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM450562(US10676446, Example 146 | N-Cyclopropyl-N-[(3,4-di...)
Affinity DataIC50: 1nMAssay Description:ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2021
Entry Details
Go to US Patent